Literature DB >> 6279682

Mouse embryos contain polypeptide growth factor(s) capable of inducing a reversible neoplastic phenotype in nontransformed cells in culture.

J A Proper, C L Bjornson, H L Moses.   

Abstract

A growth-factor-like substance capable of inducing nontransformed mouse AKR-2B, rat NRK, and EGF-receptorless mouse NR6 cells to form progressively growing colonies in soft agar was identified in acid/ethanol extracts of 17-day mouse embryos. This "mouse embryo factor" (MEF) is similar to previously described transforming growth factors in that it is capable of stimulating DNA synthesis and conferring a reversible transformed morphology on nontransformed cells in vitro. Passage of crude embryo extracts over a Bio-Gel P-60 column gave a major peak of soft agar growth-stimulating activity in the 15,000 molecular weight range with a minor peak at about 22,000. This biological activity was sensitive to treatment with either trypsin or dithiothreitol, but was unaffected by heat (56 degrees C for 30 minutes or 100 degrees C for 3 minutes), indicating that the activity is due to a heat-stable polypeptide(s) with disulfide bonds. Separation of these polypeptide(s) by chromatography on carboxymethyl cellulose revealed two peaks of soft agar growth-stimulating activity which did not cochromatograph with a peak of epidermal growth factor receptor-competing activity. The similarities of this mouse embryo-derived growth factor to previously identified transforming growth factors suggest that both fetal development and neoplastic transformation may be affected by similar mechanisms.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6279682     DOI: 10.1002/jcp.1041100210

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  20 in total

1.  Extraction and purification of TGFbeta and its effect on the induction of apoptosis of hepatocytes.

Authors:  X H Si; L J Yang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Tumor products and the hypercalcemia of malignancy.

Authors:  G R Mundy; K J Ibbotson; S M D'Souza
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

Review 3.  The Discovery and Early Days of TGF-β: A Historical Perspective.

Authors:  Harold L Moses; Anita B Roberts; Rik Derynck
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

4.  Direct demonstration of production of transforming growth factor activity by embryonic chick tissue.

Authors:  J C McLachlan; J Macintyre; D D Hume; J Smith
Journal:  Experientia       Date:  1988-04-15

5.  Isolation of an autocrine growth factor from hepatoma HTC-SR cells.

Authors:  P Ove; M L Coetzee; P Scalamogna; A Francavilla; T E Starzl
Journal:  J Cell Physiol       Date:  1987-05       Impact factor: 6.384

6.  Early mouse embryos produce and release factors with transforming growth factor activity.

Authors:  A Rizzino
Journal:  In Vitro Cell Dev Biol       Date:  1985-09

7.  Increased secretion of type beta transforming growth factor accompanies viral transformation of cells.

Authors:  M A Anzano; A B Roberts; J E De Larco; L M Wakefield; R K Assoian; N S Roche; J M Smith; J E Lazarus; M B Sporn
Journal:  Mol Cell Biol       Date:  1985-01       Impact factor: 4.272

8.  Type beta transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval.

Authors:  G D Shipley; R F Tucker; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

9.  Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets.

Authors:  R F Tucker; E L Branum; G D Shipley; R J Ryan; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

10.  Serum contains a platelet-derived transforming growth factor.

Authors:  C B Childs; J A Proper; R F Tucker; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.